Every individual carries a unique genetic heritage, a distinct metabolism, a singular microbiome. No one disputes this biological fact. Yet every morning, millions of people swallow the same standardized tablet. Multivitamins now represent a global market worth over $50 billion, and the scientific literature keeps accumulating data that challenges their relevance in this generic form.
This is an absurdity.
The fundamental problem: blind standardization
When a laboratory formulates a multivitamin, it relies on Recommended Daily Allowances (RDAs), also known as Nutrient Reference Values (NRVs). These values cover the needs of 97.5% of the general population. They ignore your age, your physical activity level, your genetic polymorphisms. MTHFR variants, which affect folate metabolism, are simply not accounted for. Neither is your actual diet.
Take vitamin D.
European RDAs recommend 5 µg (200 IU) per day. European surveys show a wide distribution of 25(OH)D concentrations and low-status prevalence across populations (PubMed). Skin pigmentation, sun exposure, body mass index, and latitude are among the biological covariates. They contextualize the measured result but provide neither a universal factor for variation in requirements nor an automatic dose.
At the same intake, achieved 25(OH)D can differ with sun exposure, pigmentation, body composition, and other covariates. None is sufficient on its own to calculate a dose.
Fat-soluble vitamins: when excess becomes the problem
The distinction between water-soluble vitamins (B group, vitamin C) and fat-soluble vitamins (A, D, E, K) is fundamental to understanding the limitations of multivitamins. Excess water-soluble vitamins are eliminated through urine. The overdose risk is low. Fat-soluble vitamins, however, accumulate in adipose tissue and the liver.
The SELECT trial illustrates this problem with brutal clarity. This randomized study followed over 35,000 men. The group supplemented with vitamin E (400 IU/day) showed a significant increase in prostate cancer risk compared to placebo (PubMed).
Supplementing without measuring is methodological recklessness.
The ignored taxonomy: essentials and geroprotectors do not belong in the same category
The multivitamin treats all bioactives as interchangeable. Yet supplementation science distinguishes two fundamentally different categories.
Essentials comprise the vitamins and minerals that the body does not synthesize in sufficient quantities: magnesium, zinc, vitamin D3, vitamin B12, iron, iodine. Being essential does not mean that every adult should receive a supplement. Two individuals of the same age, living in the same city, can have different vitamin D status depending on genetics, body fat, diet, and sun exposure; the current blood value integrates part of this context.
Geroprotectors (literally "aging protectors") form a distinct category. Research examines bioactives such as glycine and taurine for their interactions with mechanisms associated with cellular aging. This classification describes a field of research. Inclusion in a formula then requires human evidence proportionate to the intended use and an assessment of the benefit/risk balance.
The Cell study by Zeevi et al. (2015) on personalized glycemic response established a finding that has become foundational: two people eating the same food can have radically different metabolic responses (PubMed). This N=1 biology principle applies directly to supplementation. Interindividual variability renders any universal formula structurally inadequate, whether we are discussing essentials or geroprotectors.
The biomarker approach: supplementing what is actually needed
Precision longevity offers a radically different alternative: instead of hypothetically filling all possible nutrient gaps, it begins by measuring the actual biological state of each individual. A targeted blood panel evaluates circulating levels of key micronutrients. 25(OH)D (the circulating form of vitamin D) for vitamin D. Ferritin (the iron storage protein) for iron. Homocysteine and total serum B12 (circulating cobalamin, the reference measure of B12 status, cross-read with homocysteine to assess functional status) for B12 status. Serum magnesium (magnesemia, the only matrix that also detects an excess) for magnesium status.
From this biological snapshot, personalized supplementation becomes possible. Nutrients are calibrated according to the current profile, not a statistical average (PubMed). Known interactions can be considered in the formulation. Singular offers a new blood test around three months after starting or changing a formula, then roughly every six months to reassess the whole formula; season contextualizes some results without automatically recalculating the vitamin D dose.
Micronutrients are essential. The most widespread method of delivering them is not. The universal tablet rests on statistical logic that individual biochemistry contradicts with every measurement.
Precision is not a luxury, but the only approach that respects your biology.
Frequently asked questions
References
- Cashman KD et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr. 2016;103(4):1033-1044 (PubMed).
- Melhus H et al. Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med. 1998;129(10):770-778 (PubMed).
- Klein EA et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306(14):1549-1556 (PubMed).
- Zeevi D, Korem T, Zmora N, et al. Personalized Nutrition by Prediction of Glycemic Responses. Cell. 2015;163(5):1079-1094 (PubMed).
- Ordovas JM, Ferguson LR, Tai ES, Mathers JC. Personalised nutrition and health. BMJ. 2018;361:bmj.k2173 (PubMed).
